S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

VYGR Voyager Therapeutics Inc

7.82

0.05 (0.64%)

01 May 2024 - Closed

Delayed by 15 minutes

Voyager Therapeutics announces strategic shift and CEO transition

To read the full story on Seeking Alpha, click here.

Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Voyager Therapeutics Charts.

Voyager Therapeutics (NASDAQ:VYGR)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Voyager Therapeutics Charts.

Voyager Therapeutics Inc News

Voyager Therapeutics to Present Broad Set of Translational Data Supporting IV-Delivered, CNS Gene Therapy Programs Advancing Toward Clinical Trials at the ASGCT 27th Annual Meeting
Tuesday 23 April 2024 (1 week ago) • GlobeNewswire Inc.

Voyager Therapeutics Announces Selection of Development Candidate for GBA1 Program in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
Tuesday 16 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Wednesday 27 March 2024 (1 month ago) • GlobeNewswire Inc.

Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer
Wednesday 13 March 2024 (2 months ago) • GlobeNewswire Inc.

Voyager Therapeutics Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 29 February 2024 (2 months ago) • Edgar (US Regulatory)

Voyager Therapeutics Announces Selection of Gene Therapy Development Candidate for Friedreich’s Ataxia in Collaboration with Neurocrine Biosciences, Triggering Milestone Payment
Monday 26 February 2024 (2 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 23 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 23 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 22 February 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 22 February 2024 (2 months ago) • Edgar (US Regulatory)

Voyager Therapeutics Announces Fourth Quarter 2023 Conference Call and Webcast
Wednesday 21 February 2024 (2 months ago) • GlobeNewswire Inc.

More Voyager Therapeutics Inc News Articles

Newcrest Mining

S&P ASX 300 Metals and M...

Verizon Communications

National Australia Bank

Gold vs US Dollar

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions